Parexel, a global clinical development partner providing insights-driven clinical and consulting solutions to the life sciences industry, has been recognised as one of the World's Top Disability Inclusive Businesses based on its performance on the Disability Index, a leading global benchmark for disability inclusion in business.

The recognition acknowledges Parexel's organisation-wide efforts to foster an inclusive workplace while advancing accessibility for both employees and patients participating in clinical research.

Peyton Howell, Chief Executive Officer, Parexel, said, "We are proud to be recognized as a World's Top Disability Inclusive Business, an achievement that underscores our continued commitment to fostering a culture where every colleague feels valued, respected and supported. This commitment is also integral to how we operate and deliver for patients.”

“Bringing together diverse experiences and perspectives helps us design more patient-focused clinical research and develop solutions that reduce barriers to trial access and participation. Ultimately, we believe this commitment and approach support our mission to accelerate the delivery of life-changing treatments to patients around the world,” added Howell.

Parexel said the recognition reflects its continued focus on embedding inclusion into leadership, governance and corporate strategy while creating an accessible and supportive environment for employees and patients regardless of physical ability or other differences. 

The company has also established ParAbility, an executive-sponsored Business Resource Group that promotes accessibility, inclusion and support across the organisation.